Radioimmunotherapy in the pi-BCL1 B cell lymphoma model: efficacy depends on more than targeted irradiation alone.

T Illidge, J Honeychurch, A Vandersteen, M Cragg

    Research output: Contribution to journalArticlepeer-review

    Original languageEnglish
    Pages (from-to)581-591
    JournalCancer Biotherapy and Radiopharmaceuticals
    Volume15
    Publication statusPublished - 2000

    Cite this